Search research articles
Contact Us
Filters
Showing results (1131-1140 of 1,180) with videos related to
Page
of 118
Sort By:
JAMA Otolaryngology-- Head & Neck Surgery
|
April 4, 2024
Quality of Life and Depression Symptoms After Therapy De-Escalation in HPV+ Oropharyngeal Squamous Cell Carcinoma: A Nonrandomized Controlled Trial
Aru Panwar, Swapnil Shah, Abigail E Reid, et al.
The Laryngoscope
|
June 28, 2016
Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation
Alexis J Platek, Vijayvel Jayaprakash, Mihai Merzianu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 31, 2018
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study
S de Vos, L J Swinnen, D Wang, et al.
ACS Medicinal Chemistry Letters
|
August 16, 2019
Effect of Linker Stereochemistry on the Activity of Indolinobenzodiazepine Containing Antibody-Drug Conjugates (ADCs)
Emily E Reid, Katie E Archer, Manami Shizuka, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
November 7, 2009
Autofluorescence-guided surveillance for oral cancer
Vijayvel Jayaprakash, Maureen Sullivan, Mihai Merzianu, et al.
Transfusion
|
August 30, 2007
Three new high-prevalence antigens in the Cromer blood group system
Kim Hue-Roye, Christine Lomas-Francis, Larisa Belaygorod, et al.
Science Advances
|
January 17, 2025
Pellino 3 E3 ligase promotes starvation-induced autophagy to prevent hepatic steatosis
Srinivasa P Kolapalli, Carsten J Beese, Steven E Reid, et al.
Nature Communications
|
April 25, 2019
Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions
Jennifer E Beane, Sarah A Mazzilli, Joshua D Campbell, et al.
Molecular Cancer Therapeutics
|
May 25, 2016
A New Class of Antibody-Drug Conjugates with Potent DNA Alkylating Activity
Michael L Miller, Nathan E Fishkin, Wei Li, et al.
Endocrinology
|
May 29, 2004
Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo
Jillian Cornish, Karen E Callon, Dorit Naot, et al.
Page
of 118
Search research articles
Search
Showing results (1131-1140 of 1,180) with videos related to
Sort By:
Page
of 118
JAMA Otolaryngology-- Head & Neck Surgery
|
April 4, 2024
Quality of Life and Depression Symptoms After Therapy De-Escalation in HPV+ Oropharyngeal Squamous Cell Carcinoma: A Nonrandomized Controlled Trial
Aru Panwar, Swapnil Shah, Abigail E Reid, et al.
The Laryngoscope
|
June 28, 2016
Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation
Alexis J Platek, Vijayvel Jayaprakash, Mihai Merzianu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 31, 2018
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study
S de Vos, L J Swinnen, D Wang, et al.
ACS Medicinal Chemistry Letters
|
August 16, 2019
Effect of Linker Stereochemistry on the Activity of Indolinobenzodiazepine Containing Antibody-Drug Conjugates (ADCs)
Emily E Reid, Katie E Archer, Manami Shizuka, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
November 7, 2009
Autofluorescence-guided surveillance for oral cancer
Vijayvel Jayaprakash, Maureen Sullivan, Mihai Merzianu, et al.
Transfusion
|
August 30, 2007
Three new high-prevalence antigens in the Cromer blood group system
Kim Hue-Roye, Christine Lomas-Francis, Larisa Belaygorod, et al.
Science Advances
|
January 17, 2025
Pellino 3 E3 ligase promotes starvation-induced autophagy to prevent hepatic steatosis
Srinivasa P Kolapalli, Carsten J Beese, Steven E Reid, et al.
Nature Communications
|
April 25, 2019
Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions
Jennifer E Beane, Sarah A Mazzilli, Joshua D Campbell, et al.
Molecular Cancer Therapeutics
|
May 25, 2016
A New Class of Antibody-Drug Conjugates with Potent DNA Alkylating Activity
Michael L Miller, Nathan E Fishkin, Wei Li, et al.
Endocrinology
|
May 29, 2004
Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo
Jillian Cornish, Karen E Callon, Dorit Naot, et al.
Page
of 118